Medical Disclaimer: This content is for educational and informational purposes only and is not intended as medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider before making any health-related decisions. If you are experiencing a medical emergency, call your local emergency services immediately.
What This Page Explains
This page provides an evidence-graded summary of what preclinical research and early human studies suggest about fisetin supplementation. The vast majority of evidence remains preclinical, with human evidence classified as early-stage/emerging.
A Simple Question: Are You Feeding Your Cells or Starving Them?
Your mitochondria need specific compounds to function optimally. Most diets — even healthy ones — fall short. Here's how to close the gap.
Detailed Evidence
The landmark Yousefzadeh et al. (2018) study demonstrated that fisetin extended lifespan in naturally aging mice. In human adipose tissue explants tested ex vivo, fisetin reduced senescent cell markers at concentrations of 10–20 μM. A clinical trial (NCT06133634) studying fisetin's effects on vascular function in older adults is actively underway.
Evidence Hierarchy
Systematic Reviews & Meta-Analyses
Multiple high-quality trials combined
Randomized Controlled Trials (RCTs)
Gold standard for treatment efficacy
Observational Studies
Can show associations, not causation
Case Reports & Expert Opinion
Hypothesis-generating only
Preclinical (Lab/Animal) Studies
Should NOT be extrapolated to humans
The Day Your Cells Start Working For You Again
Imagine waking up with clean energy, sharp focus, and resilient recovery. That's what happens when your mitochondria get what they need.
Study Quality Indicators
Higher Quality Indicators
- Large sample size (hundreds to thousands)
- Randomized and blinded design
- Placebo-controlled comparison
- Published in peer-reviewed journals
- Replicated in multiple studies
- Registered trial protocol before starting
Lower Quality Indicators
- Small sample size (under 100)
- No control group or blinding
- Manufacturer-funded with conflicts
- Only animal/cell studies
- Never replicated
- Published in predatory journals
Important Limitations
- • Supplement research often has methodological limitations
- • Results from one study may not generalize to all people
- • Marketing claims often exceed what research supports
- • Absence of evidence is not evidence of absence
- • Individual response to supplements varies widely
Quick Answers
What are the proven benefits of fisetin?
In preclinical studies: senolytic activity, lifespan extension in mice, reduced inflammatory markers, neuroprotective effects. In humans: safety demonstrated in early trials; efficacy outcomes are still under investigation.
Does fisetin help with aging?
In mice, yes — late-life fisetin treatment extended median and maximum lifespan. In humans, this has not been demonstrated and remains under investigation.
Can fisetin improve heart health?
A clinical trial (NCT06133634) is actively studying fisetin's effects on vascular function in older adults. Results are anticipated but not yet published.
Does fisetin reduce inflammation in humans?
Multiple animal studies show fisetin reduces inflammatory biomarkers. The COVID-19 senolytic trial (COVFIS) provided some early human data, but the study was primarily designed to assess safety.
Is fisetin good for the brain?
In animal models of Alzheimer's disease and cognitive aging, fisetin has shown improvements in memory and reductions in neuroinflammation. These are exclusively preclinical findings.
Does fisetin have anti-cancer effects?
Preclinical cancer research shows fisetin effects in cell models of lung, colon, breast, prostate, and pancreatic cancer — none translated to human trials.
What level of evidence supports fisetin?
Fisetin's evidence grade is classified as 'preclinical/early human' — the strongest evidence comes from mouse studies; human evidence is limited to small Phase I–II trials.
Is fisetin better than other senolytics?
In the 2018 Mayo Clinic screening, fisetin showed greater senolytic potency than quercetin and 8 other flavonoids. Comparison to pharmaceutical senolytics (dasatinib, navitoclax) has not been established.
Does fisetin help with frailty?
The COVFIS trial demonstrated safety and feasibility of fisetin in frail elderly populations. Efficacy for frailty outcomes is under investigation.
Should I take fisetin for longevity?
No human trial has demonstrated that fisetin extends human lifespan. Claims beyond published research are not supported by evidence. Consult a qualified healthcare provider.
Key Research Facts
Fisetin treatment started in 85-week-old mice (equivalent to ~75 human years) extended remaining lifespan by approximately 10% in both median and maximum.
Strong EvidenceYousefzadeh et al., EBioMedicine — doi:10.1016/j.ebiom.2018.09.015
In human adipose tissue explants, fisetin reduced senescent cell viability markers at concentrations of 10–20 μM ex vivo.
Moderate EvidenceYousefzadeh et al., EBioMedicine — doi:10.1016/j.ebiom.2018.09.015
The COVFIS trial demonstrated safety and feasibility of fisetin in frail elderly populations but was not designed to demonstrate clinical efficacy.
Moderate EvidenceVerdoorn et al., JAGS — doi:10.1111/jgs.17416
Preclinical cancer research shows fisetin effects in cell models of lung, colon, breast, prostate, and pancreatic cancer — none translated to human trials.
Moderate EvidenceSundarraj et al., Biomedicine & Pharmacotherapy — doi:10.1016/j.biopha.2017.10.164
In rodent neurodegeneration models, fisetin improved memory performance and reduced neuroinflammatory markers in hippocampal tissue.
Moderate EvidenceKhan et al., Antioxidants & Redox Signaling — doi:10.1089/ars.2012.4901
No published human study has demonstrated that oral fisetin achieves senolytic tissue concentrations or produces measurable senescent cell clearance.
Strong EvidenceLiterature review — PubMed search, 2026
Fisetin's evidence grade is classified as 'preclinical/early human' — the lowest tier on the standard evidence hierarchy for clinical recommendations.
Strong EvidenceEvidence hierarchy assessment — Oxford CEBM levels of evidence
Citations & External Resources
ClinicalTrials.gov — Search: Fisetin
EBioMedicine — Yousefzadeh et al. 2018 (Landmark Senolytic Study)
Antioxidants & Redox Signaling — Khan et al. 2013 (Comprehensive Review)
JAGS — Verdoorn et al. 2021 (COVFIS Trial)
Why Everything You've Tried for Energy Has Failed
Because none of it reached your mitochondria. Vitamins, adaptogens, superfoods — none of them address the core mechanism. Until now.
Related Reading
Fisetin: Overview, Evidence & Safety
How Fisetin Works: Senolytic Mechanisms
Fisetin Side Effects & Safety
References (3)
Written by
ReCellence™ Editorial Team
Health Content Specialists
Medically reviewed by
Medical Review Board
MD, PhD
Last updated: March 8, 2026
Last medical review: March 8, 2026